Skip to main content

Rexall Nicotine

NDC 55910-957 · Dolgencorp, LLC

Generic nameNicotine Polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

55910-957-60 — 1 CONTAINER in 1 CARTON (55910-957-60) / 20 LOZENGE in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55741-446 — Nicotine Transdermal System Patch, 55741-447 — Nicotine Transdermal System Patch, 55741-448 — Nicotine Transdermal System Patch, 55910-122 — Nicotine Polacrilex, 55910-313 — Nicotine, 55910-662 — Nicotine Polacrilex, 55910-669 — Nicotine Polacrilex, 55910-796 — Nicotine Polacrilex, 55910-918 — Nicotine Polacrilex, 55910-933 — Nicotine Polacrilex, 55910-976 — Nicotine Polacrilex, 56062-019 — Nicotine Polacrilex, 56062-110 — Nicotine Polacrilex, 56062-298 — Nicotine Polacrilex, 56062-344 — Nicotine Polacrilex, 56062-369 — nicotine polacrilex, 56062-428 — Nicotine Polacrilex, 56062-429 — Nicotine Polacrilex, 56062-499 — Nicotine Polacrilex, 56062-503 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels